Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. 2023-05-18 21:23
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA 2023-05-18 21:00
CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S. 2023-05-18 20:50
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023 2023-05-18 20:25
DISCOVERY LIFE SCIENCES JOINS AKOYA BIOSCIENCES' GLOBAL SERVICE PROVIDER NETWORK TO ACCELERATE IMMUNO-ONCOLOGY RESEARCH 2023-05-18 20:05
Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility 2023-05-18 20:05
AIA Hong Kong to launch market-first critical illness product "AIA Assemble" 2023-05-18 17:54
Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to exhibit at Medtec China 2023 2023-05-18 17:02
CPIC Continuously Improving the Construction of the "Insurance + Service" Ecosystem to Safeguard a Better Life for Residents 2023-05-18 16:38
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Malaysia Healthcare Travel Council Expands Global Reach 2023-05-18 14:28
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus 2023-05-18 14:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 11:53
Gleneagles Hospital Kuala Lumpur Applauded by Frost & Sullivan for Its Initiatives in Improving the Patient Experience and Customer Value 2023-05-18 10:13
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
Providence-based "Biotech start up" EpiVax Celebrates 25th Anniversary 2023-05-17 23:49
Biomerics Announces Merger with Precision Concepts Medical 2023-05-17 22:00
LBB Specialties Announces Senior Vice President of Personal Care 2023-05-17 21:50
Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan 2023-05-17 21:13
1 225 226 227 228 229 1594